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Introduction
Multidrug resistant (MDR) gram-negative bacteria have 
resistance to many antimicrobial compounds by multiple 
mechanisms including reduced outer membrane perme-
ability, and active efflux mechanisms by efflux pumps. 
Efflux pumps in pathogenic bacteria and their roles in 
excreting entered antimicrobial agents to outer vicinity of 
the cell is one of several mechanisms that lead to bacterial 
drug resistances (1). 
Reports show this mechanism is involved in fluoroquino-
lone resistance in gram negative pathogenic bacteria, af-
fecting hospitalized patients (2). The result of over expres-
sion of these pumps in pathogenic bacteria is the emer-
gence of pathogenic strains that are clinically resistance to 
many antimicrobial agents such as ciprofloxacin (3).
Phenylalanyl-arginyl-beta-naphthylamide (PAßN) is a 
compound that has become known as a chemical efflux 
pump inhibitor (EPI) (4). PAßN selectively inhibits the 
efflux activities of a broad range of efflux pumps such 
as MexAB-OprM, MexEF-OprN, MexCD-OprJ, and 
MexXY-OprM in P. aeruginosa and AcrAB-TolC in some 
species of the Enterobacteriaceae (5).
It has been reported that the extracts from some medici-
nal plants contain compounds that inhibit efflux pumps 
of bacteria and can be considered as EPIs (6). Berberis 
vulgaris asperma is a medicinal herb that traditionally is 
used for its medicinal properties. Reports indicated that 
Berberis species contain compounds that could enhance 
antibacterial actions of some antimicrobial agents and 
also have many beneficial effects such as anti-bacterial 
properties (7). 
This study was planned to search the antibacterial activi-
ties of the ethanol and Chloroform extracts of Berberis 
vulgaris asperma stem and their synergistic effects with 
ciprofloxacin as a fluoroquinolone representative against 
some gram-negative pathogenic bacteria. 
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Implication for health policy/practice/research/medical education:
Various extracts from B. vulgaris asperma stem were able to act as antibacterial agents and increase the susceptibility of 
pathogenic bacteria to ciprofloxacin. The present data may bring about primary information for the possible use of these extracts 
in association with fluoroquinolones to combat at least some gram negative pathogens.
Please cite this paper as: Ebrahimi A, Chavoushpour M, Mahzoonieh MR, Lotfalian S. Antibacterial activity and ciprofloxacin-
potentiation property of Berberis vulgaris asperma stem extracts on pathogenic bacteria. J HerbMed Pharmacol. 2016;5(3):112-115. 
Introduction: This study was planned to search the antibacterial activities of the ethanol 
and Chloroform extracts of Berberis vulgaris asperma stem and their synergistic effects with 
ciprofloxacin against some gram-negative pathogenic bacteria. 
Methods: Broth micro-dilution method was used for determination of minimum inhibitory 
concentrations (MICs) of the extracts alone or in association with ciprofloxacin and Phenylalanine-
Arginine β-Naphtylamide (PAβN) as a positive control and efflux pumps inhibitor (EPI). 
 Results: MIC determination indicated that the extracts from Berberis vulgaris asperma stem were 
able to inhibit the growth of all the studied bacteria within a concentration range of 3900 to 37500 
µg/mL. Synergistic effects were noted between the extracts from Berberis vulgaris asperma stem 
extracts and ciprofloxacin on all tested bacteria except Acinetobacter bummani. 
Conclusion: Berberis vulgaris asperma stem extracts act as an antibacterial agent and potentiate 
ciprofloxacin effects on examined pathogenic bacteria. 
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Materials and methods
Dried stems of Berberis vulgaris asperma were prepared 
from Khorasan province local markets and transferred 
to microbiology laboratory of veterinary college of 
Shahrekord university. After grinding, the resulting pow-
der was extracted with ethanol 85% and chloroform for 48 
hours at 25°C. After filtration the extracts were concen-
trated under vacuum (8). All extracts were kept at 4°C for 
further investigations.
Bacterial cultures and materials
The studied microorganisms included the reference 
strains of Pseudomonas aeruginosa ATCC 9027, Acineto-
bacter baumannii NCTC 13305, Escherichia coli ATCC 
25922 and Salmonella enteritidis RTCC 2465, were kept in 
Lauria Bertani broth (LB broth) at 4°C and sub-cultured 
on appropriate agar plates 24 hours prior to antimicrobial 
tests. Mueller Hinton broth (MHB) was used for all the 
antibacterial assays. Ciprofloxacin (CIP) (Sigma-Aldrich) 
as fluoroquinolone representative and Phenylalanine argi-
nine β-aphthylamide (PAβN) (Sigma-Aldrich) as micro-
bial growth indicator and EPI were used, respectively.
Antimicrobial testing
After a preliminary assay by tube dilution method on ex-
amined drugs against four standard bacterial strains, the 
MICs for drug combinations were determined following 
the method of double-serial micro dilution, according 
to guidelines of the Clinical and Laboratory Standards 
Institute (9). Briefly, the bacterial cultures were incu-
bated aerobically at 37°C for 18-24 hours. The turbidity 
of the cultures adjusted to 0.5 McFarland (1.5×108 CFU/
ml) and then diluted in saline solution so that to obtain 
an inoculum of 5×105 CFU/well. The first well of each 96 
well micro plate row inoculated with four MIC of drug/
drugs followed by double dilution in successive wells to 
detect any possible antagonistic or synergistic combina-
tions. The two last wells were considered as positive and 
negative controls. 
The inoculated micro plates were aerobically incubated 
in shaking for about 18 hours at 37°C. The lowest con-
centration that inhibited visible growth after incubation 
was defined as MIC. For verifying synergistic activity of 
ciprofloxacin with the extracts, activity of ciprofloxacin 
with extract associations was compared with that of cipro-
floxacin plus PAßN (30 µg/ml in prepared stock solution) 
whose antimicrobial activity was also tested.
Interaction of drugs in combinations was calculated as the 
ratio of MICAntibiotic in combination/MICAntibiotic alone and 
the results were discussed as follows: synergy (<0.5), in-
different (0.5 to 4), or antagonism (>4) (10,11). All assays 
were performed in duplicate.
Results
Ethanol and chloroform extracts of Berberis vulgaris 
asperma stem were examined to detect synergy with cip-
rofloxacin. The positive control was PAβN whose antimi-
crobial activity was also assayed on the examined strains 
(Table 1).
The MICs of ethanolic and chloroform extracts and drug 
combinations against examined bacteria are appeared in 
Table 1. Of the extracts investigated, the chloroform ex-
tract generally showed a greater activity against examined 
bacteria, (MIC, 3900 to 7810 μg/mL.). By MIC determi-
nation, chlorophorm extract of Berberis vulgaris asperma 
stem showed synergistic activity with ciprofloxacin against 
all of the examined bacteria other than A. bummani (Table 
1). However, for ethanol extract this synergy was recorded 
only against E. coli and S. enteritidis. In A. bummani there 
were no synergy with ciprofloxacin, PAβN also did not re-
duce the MIC of ciprofloxacine (Table 1).
Discussion
There is continued clinical pressure for novel approaches 
to combat antibiotic-resistances and identifying new an-
timicrobials for treating resistant bacterial infections. 
Screening plants for natural products with antibiotic po-
tentiating effects was a successful approach (7). So, in the 
present work we examined Berberis vulgaris asperma stem 
ethanolic and chloroform extracts for antibacterial activ-
ity and possible synergy with ciprofloxacin.
The examined bacterial strains tested with a combination 
of Berberis vulgaris asperma extracts, ciprofloxacin and 
PAβN all contained multidrug resistance efflux pumps 
(3,12). It appears that extracts of B. vulgaris asperma stem 
prevent the growth of all examined bacterial strains in 
Table 1.  MICs (μg/mL) of CIP, and PAβN in the absence and presence of Berberis vulgaris asperma stem extracts against some gram negative 
Bacteriaa
Combination 
PAβN+Cip CIP Eth.E.+ CIP Eth.E. Ch.E. + CIP Ch.E. PAβN  
Bacteria
Ps. aeruginosa
0.125 1 0.625 3125 0.19 4680 3.75
S. enteritidis
0.05
0.008 0.003 37500 0.003 3900 5
E. coli
0.002
0.007 0.0015 25000 0.0002 7810 6.25
A. baumannii
R
0.26 0.2 37500 0.4 6250 6.25
Abbreviations: Eth.E., ethanolic extracts; Ch. E., chloroform extract; CIP, ciprofloxacin respectively; MIC, Minimum inhibitory concentration; PAβN, 
phenylalanine arginine β-aphthylamide.
a Synergistic combinations appeared as bold numbers.
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3900 to 37500 µg/mL concentration range (Table 1). The 
lowest MIC value (3900 μg/mL.) was obtained with the 
Chloroform extract of B. vulgaris asperma stem against S. 
enteritidis.
Reports show other plant extracts contain compounds 
that potentiate antibiotic activity or have antibacterial 
activity (14). Also it has been reported that essential oil 
from a Corsican plant, Helichrysum italicum, reduced the 
MIC of chloramphenicol against Enterobacter aerogenes, 
A. baumannii and P. aeruginosa (14).
In terms of antibiotic potentiation with ciprofloxacin the 
chloroform extract of B. vulgaris asperma stem showed the 
best activity against S. enteritidis, E. coli and pseudomonas 
aeroginosa. The best synertgistic activities of ethanolic 
extract were recorded against two former bacteria. These 
observations may imply that B. vulgaris asperma stem ex-
tracts contain active compounds that target the bacterial 
cell and might be powerful substrates of mentioned bacte-
rial efflux pumps. As ciprofloxacin is a substrate of many 
bacterial efflux pumps (1), many reports indicate activity 
of other plant extracts that synergised with this agent (15).
A. baumannii, PAβN and association of extracts had no 
effect on MIC of ciprofloxacin. Since the presence of AcrB 
efflux pumps confers resistance to the cells against PAβN 
(16), this may implies that our examined strain of A. bau-
mannii over expressed AcrB efflux pumps and the extracts 
from B. vulgaris asperma stem may also behave the same 
as PAβN.
It is also worth to note that PAβN cannot reverse drug re-
sistance for all drugs and has, for instance, no effect on 
efflux pump-mediated resistance to the dye ethidium (17). 
Berberine is an isoquinoline-type alkaloid with antimi-
crobial properties isolated from many kinds of Berberis 
species such as Berberis aristata, Berberis aquifolium and 
Berberis vulgaris. The synergistic effects of extracts of B. 
vulgaris asperma stem with other antibiotics were noted 
on other bacteria also indicate that extracts of this herb 
can act as EPI (18). However, a detailed study on active 
constituents, phytochemical and toxicological properties 
of B. vulgaris asperma stem is suggested for evaluating its 
safety.
Taking together, from our results we can suggest that us-
ing the extracts of B. vulgaris asperma stem in associations 
with fluoroquinolones might be helpful in treating infec-
tions caused by Pseudomonas aeruginosa, E. coli and Sal-
monella enteritidis strains. 
In conclusion extracts from B. vulgaris asperma stem were 
able to increase susceptibility to ciprofloxacin and the 
present investigation brings about primary information 
for the possible use of these extracts in association with 
fluoroquinolones to combat at least some gram negative 
pathogens.
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